FDA Inspection 745721 — Biomat USA, Inc.

Biomat USA, Inc. — FEI 3006811800

The FDA completed an inspection of Biomat USA, Inc. on September 20, 2011 in Terre Haute, IN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 20, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Terre Haute, IN (United States)

Citations

IDCFRDescription
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
7721 CFR 606.100(b)Written SOPs available for use by personnel